PRODUCTS
SERVICES
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
2.23
2 yrs 9 m
1%
2,611.33 Crs
1% on or before 30D, Nil after 30D
Mid Growth
8.2
SIP 100 & Lumpsum 100
BSE HEALTH CARE - TRI
Nikhil Mathur
Investors understand that their principal will be at very high risk